KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Notes Payables (2017 - 2023)

Pacific Biosciences Of California has reported Notes Payables over the past 8 years, most recently at $500000.0 for Q4 2023.

  • Quarterly results put Notes Payables at $500000.0 for Q4 2023, down 78.26% from a year ago — trailing twelve months through Dec 2023 was $500000.0 (down 78.26% YoY), and the annual figure for FY2023 was $500000.0, down 78.26%.
  • Notes Payables for Q4 2023 was $500000.0 at Pacific Biosciences Of California, down from $2.3 million in the prior quarter.
  • Over the last five years, Notes Payables for PACB hit a ceiling of $15.9 million in Q4 2019 and a floor of $500000.0 in Q4 2023.
  • Median Notes Payables over the past 4 years was $14.9 million (2019), compared with a mean of $9.4 million.
  • Biggest five-year swings in Notes Payables: skyrocketed 43.03% in 2022 and later plummeted 78.26% in 2023.
  • Pacific Biosciences Of California's Notes Payables stood at $15.9 million in 2019, then tumbled by 89.87% to $1.6 million in 2021, then soared by 43.03% to $2.3 million in 2022, then plummeted by 78.26% to $500000.0 in 2023.
  • The last three reported values for Notes Payables were $500000.0 (Q4 2023), $2.3 million (Q4 2022), and $1.6 million (Q4 2021) per Business Quant data.